References
- RamalingamSBelaniCSystemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directionsOncologist200813Suppl 151318263769
- ZhouHGaoSNguyenNNStringent homology-based prediction of H. sapiens-M. tuberculosis H37Rv protein-protein interactionsBiol Direct20149524708540
- ZhouHJinJZhangHYiBWozniakMWongLIntPath – an integrated pathway gene relationship database for model organisms and important pathogensBMC Syst Biol20126Suppl 2S2
- PortalDZhouHZhaoBEpstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2Proc Natl Acad Sci U S A2013110185371854224167291
- DelpuYCordelierPChoWCTorrisaniJDNA methylation and cancer diagnosisInt J Mol Sci201314150291505823873296
- MaXWangYWZhangMQGazdarAFDNA methylation data analysis and its application to cancer researchEpigenomics2013530131623750645
- Ghavifekr FakhrMFarshdousti HaghMShanehbandiDBaradaranBDNA methylation pattern as important epigenetic criterion in cancerGenet Res Int2013201331756924455281
- FleischhackerMDietrichDLiebenbergVFieldJKSchmidtBThe role of DNA methylation as biomarkers in the clinical management of lung cancerExpert Rev Respir Med2013736338323964627
- OhtaMInoueHCotticelliMGThe FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancersCell1996845875978598045
- PekarskyYCampiglioMSiprashviliZNitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegansProc Natl Acad Sci U S A199895874487499671749
- RomeroIMartinezMGarridoCThe tumour suppressor Fhit positively regulates MHC class I expression on cancer cellsJ Pathol201222736737922451343
- PichiorriFPalumboTSuhSSFhit tumor suppressor: guardian of the preneoplastic genomeFuture Oncol2008481582419086848
- HassanMINaiyerAAhmadFFragile histidine triad protein: structure, function, and its association with tumorogenesisJ Cancer Res Clin Oncol201013633335020033706
- PekarskyYPalamarchukAHuebnerKCroceCMFHIT as tumor suppressor: mechanisms and therapeutic opportunitiesCancer Biol Ther2002123223612432269
- HuangQLiuZXieFFragile histidine triad (FHIT) suppresses proliferation and promotes apoptosis in cholangiocarcinoma cells by blocking PI3K-Akt pathwayScientificWorldJournal2014201417969824757411
- RimessiAMarchiSFotinoCIntramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosisProc Natl Acad Sci U S A2009106127531275819622739
- TrapassoFPichiorriFGaspariMFhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cellsJ Biol Chem2008283137361374418319262
- TanSSunCWeiXQuantitative assessment of lung cancer associated with genes methylation in the peripheral bloodExp Lung Res20133918219023614702
- VerriCRozLConteDFragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer projectAm J Respir Crit Care Med200917939640119096006
- CantorJPIliopoulosDRaoASEpigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicityInt J Cancer2007120243117019711
- HanSYIliopoulosDDruckTCpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumorsOncogene2004233990399815007387
- McShaneLMAltmanDGSauerbreiWTaubeSEGionMClarkGMReporting recommendations for tumor marker prognostic studies (REMARK)J Natl Cancer Inst2005971180118416106022
- SteelsEPaesmansMBerghmansTRole of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysisEur Respir J20011870571911716177
- DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials198671771883802833
- HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ200332755756012958120
- DerSimonianRMeta-analysis in the design and monitoring of clinical trialsStat Med19961512371248 discussion 49–528817798
- EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ19973156296349310563
- HarounRAZakharyNIMohamedMRAbdelrahmanAMKandilEIShalabyKAAssessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patientsAsian Pac J Cancer Prev2014154281428724935385
- LiWDengJTangJXCombined effects methylation of FHIT, RASSF1A and RARbeta genes on non-small cell lung cancer in the Chinese populationAsian Pac J Cancer Prev2014155233523725040980
- Zochbauer-MullerSFongKMMaitraA5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancerCancer Res2001613581358511325823
- HsuHSChenTPHungCHCharacterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasmaCancer20071102019202617876837
- YanagawaNTamuraGOizumiHEndohMSadahiroMMotoyamaTInverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking statusAnticancer Res2011311211121421508367
- SongHYiJZhangYWangRChenLDNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancerZhongguo Fei Ai Za Zhi201114233238 Chinese21426665
- LiWDengJJiangPTangJAssociation of 5′-CpG island hypermethylation of the FHIT gene with lung cancer in southern-central Chinese populationCancer Biol Ther201010997100020814237
- LiHZhangWLiWYinCEffects of methylation of FHIT gene on it’s protein and mrna expression in non-small cell lung cancerZhongguo Fei Ai Za Zhi200912760764 Chinese20719151
- YanagawaNTamuraGOizumiHPromoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancersLung Cancer20075813113817606310
- KimDSChaSILeeJHAberrant DNA methylation profiles of non-small cell lung cancers in a Korean populationLung Cancer2007581617532092
- KimJSKimJWHanJShimYMParkJKimDHCohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancerCancer Res2006664049405416618724
- NakataSSugioKUramotoHThe methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significanceCancer20061062190219916598757
- IliopoulosDGulerGHanSYFragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancerOncogene2005241625163315674328
- TomizawaYIijimaHNomotoTClinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancerLung Cancer20044630531215541815
- TzaoCTsaiHYChenJTChenCYWangYC5′CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancerEur J Cancer2004402175218315341994
- KimJSKimHShimYMHanJParkJKimDHAberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lungCarcinogenesis2004252165217115231689
- MaruyamaRSugioKYoshinoIMaeharaYGazdarAFHypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinomaCancer20041001472147715042681
- JeongYJJeongHYLeeSMBongJGParkSHOhHKPromoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patientsOncol Rep2013302270227823969757
- Al-TemaimiRAJacobSAl-AliWThomasDAAl-MullaFReduced FHIT expression is associated with mismatch repair deficient and high CpG island methylator phenotype colorectal cancerJ Histochem Cytochem20136162763823797051
- BanzaiCNishinoKQuanJPromoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinomaInt J Clin Oncol20141912713223494221
- PaluszczakJMisiakPWierzbickaMWozniakABaer-DubowskaWFrequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosaOral Oncol20114710410721147548
- YinDTWangLSunJAssociation of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinomaInt J Clin Exp Pathol2010348249120606729
- YanagawaNOsakabeMHayashiMTamuraGMotoyamaTFrequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomasVirchows Arch200845237738218299890
- LeeEJLeeBBKimJWAberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinomaEur J Cancer20064297298016564166
- ZhengSMaXZhangLHypermethylation of the 5′ CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemiaCancer Res2004642000200615026336
- CecenerGTuncaBEgeliUThe promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastomaCell Mol Neurobiol20123223724421928112
- WaliAFHIT: doubts are clear nowScientificWorldJournal2010101142115120563537
- AndrianiFRozECaseriniRInactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancerJ Thorac Oncol2012763164222425911
- TakadaSMoritaKHayashiKMethylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with multiple myelomaEur J Haematol20057550551016313263
- WuQShiHSuoZNeslandJM5′-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomasUltrastruct Pathol20032741742214660280
- ShimadaYSatoFWatanabeGLoss of fragile histidine triad gene expression is associated with progression of esophageal squamous cell carcinoma, but not with the patient’s prognosis and smoking historyCancer20008951110896994